Back

Pulmonary hypertension is an adverse risk factor for patients admitted with atrial fibrillation

28 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Predictors for atrial fibrillation Clinical ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mouna Kodali

Aurora Sinai Aurora St. Lukes Medical Centers, Milwaukee (United States of America)

7 More presentations in this session

Presentation thumbnail
Epicardial fat can predict the in-atrial thrombus in patients with atrial fibrillation
Doctor M. Tang (CN)
Abstract Slides Video
Presentation thumbnail
A cardiac rehabilitation and those effects using cardiopulmonary exercise testing in patients undergoing catheter ablation for atrial fibrillation
Doctor S. Maeda (Kawasaki, JP)
Abstract Slides Video
Presentation thumbnail
The association of vasoactive agents with postoperative atrial fibrillation after cardiac surgery
Doctor A. Hammer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Patterns of comorbidities and influence on the natural history of patients with atrial fibrillation: a latent class analysis from a prospective observational european AF registry
Doctor G. Romiti (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Role of liver disease in management and outcomes of european and asian patients with atrial fibrillation: a report from two regional prospective observational AF registries
Doctor D. Mei (Modena, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Predictors for atrial fibrillation

The Event

Event poster

ESC Congress 2023

28 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical consequences of atrial fibrillation in pulmonary arterial hypertension: insights from a large real-world cohort
thumbnail
Congress Presentation
Preexisting pulmonary hypertension impact on in-hospital outcomes of cardiac implantable electrical device implantation
thumbnail
Congress Session
Registries on atrial fibrillation and sudden death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources